Where Investors Are Going — New Reports on Agrieuro, Fannie Mae, Freddie Mac and Amarantus Bioscience

NEW YORK, NY / ACCESSWIRE / December 16, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Agrieuro Corp. (OTC: EURI), Federal National Mortgage Association (OTC: FNMA), Federal Home Loan Mortgage Corp. (OTC: FMCC) and Amarantus Bioscience Holdings Inc. (OTC: AMBS). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

EURI Research Package: http://www.traders-choice.com/pdf?s=EURI

FNMA Research Package: http://www.traders-choice.com/pdf?s=FNMA

FMCC Research Package: http://www.traders-choice.com/pdf?s=FMCC

AMBS Research Package: http://www.traders-choice.com/pdf?s=AMBS

============

Highlights from today’s reports include:

On Tuesday, December 15, 2015, the NASDAQ Composite ended at 4,995.36, up 0.87%, the Dow Jones Industrial Average advanced 0.90%, to finish the day at 17,524.91, and the S&P 500 closed at 2,043.41, up 1.06%.

– Agrieuro Corp.’s stock edged lower by 10.82% to close Tuesday’s session at USD 0.65. The company’s shares oscillated between USD 0.63 and USD 0.71 in trade during the day. The stock recorded a trading volume of 1.30 million shares, which was above its 50-day daily average volume of 1.15 million shares and above its 52-week average volume of 1.08 million shares. Over the last three days, Agrieuro Corp.’s shares have declined by 15.23% and in the past one week the shares have moved down 1.96%. However, in the past one month the shares have advanced 21.68% and over the last three months, the stock has gained 62.75%. The shares of the company are trading at a price to book ratio of 12.6. The stock has a 50-Day Moving Average of USD 0.73 and a 200-day Moving Average of USD 0.89.

– The stock of Federal National Mortgage Association (commonly known as Fannie Mae) lost 0.56% to close Tuesday’s session at USD 1.77. The shares of the company moved in the range of USD 1.76 and USD 1.91 during the day. A trading volume of 6.31 million shares was recorded, which was greater than its 150-day daily average volume of 3.43 million shares and above its 52-week average volume of 4.62 million shares. Over the last five days, Federal National Mortgage Association’s shares have declined by 11.94% and in the past one month, the shares have lost 19.91%. Additionally, over the last three months, the stock has declined 20.98% and in the past six months, the shares have registered a loss of 30.59%. The stock is trading at a price to sales ratio of 0.02. The stock has a 50-Day Moving Average of USD 2.12 and a 200-day Moving Average of USD 2.30.

– The stock of Federal Home Loan Mortgage Corp. (also known as Freddie Mac) decreased by 0.57% to close Tuesday’s session at USD 1.75. The company’s shares fluctuated in the range of USD 1.74 and USD 1.93 during the day. A total of 3.17 million shares exchanged hands, which surpassed its 50-day daily average volume of 1.91 million shares and was above its 52-week average volume of 2.29 million shares. Over the last three days Federal Home Loan Mortgage Corp.’s shares have declined by 9.79% and in the past one week the shares have moved down 12.50%. Furthermore, over the last three months, the stock has lost 18.60% and in the past six months, the shares have shed 28.72%. The stock is trading at a price to sales ratio of 0.02. The stock has a 50-Day Moving Average of USD 2.10 and a 200-day Moving Average of USD 2.23.

– Amarantus Bioscience Holdings Inc.’s stock added 44.44% to close Tuesday’s session at USD 0.65. The company’s shares oscillated between USD 0.43 and USD 0.66 in trade during the day. The stock recorded a trading volume of 1.17 million shares, which was above its 50-day daily average volume of 0.54 million shares and above its 52-week average volume of 0.14 million shares. Over the last five days, Amarantus Bioscience Holdings Inc.’s shares have declined by 15.03% whereas in the past one month, the shares have gained a momentum of 80.56%. In addition, over the last three months, the stock has lost 67.17% and year to date; the shares have shed 94.73%. The stock has a 50-Day Moving Average of USD 0.21 and a 200-day Moving Average of USD 0.50.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 434788